GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Asset Impairment Charge

China National Accord Medicines (SZSE:000028) Asset Impairment Charge

: ¥0 Mil (TTM As of Dec. 2023)
View and export this data going back to 1993. Start your Free Trial

China National Accord Medicines's Asset Impairment Charge for the three months ended in Dec. 2023 was ¥0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was ¥0 Mil.

China National Accord Medicines Asset Impairment Charge Historical Data

The historical data trend for China National Accord Medicines's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

China National Accord Medicines Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Asset Impairment Charge Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

China National Accord Medicines Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

China National Accord Medicines Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:000028) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Asset Impairment Charge
Comparable Companies
SHSE:600739 SHSE:600056 SZSE:000950 SHSE:603368 SHSE:600511 SZSE:002589 SZSE:002551 SHSE:601607 MCK COR CAH HSIC MIL:AMP HKSE:01099 XSWX:GALE NZSE:EBO TSE:7459 TSE:2784 PDCO TSE:9987
Traded in Other Exchanges
200028:China
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
Website
http://www.szaccord.com.cn
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines